#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Alveolar rhabdomyosarcoma Antithrombin III deficiency Hypergammaglobulinaemia benign monoclonal Microvillous inclusion disease Acute myeloid leukaemia refractory Cardiac failure acute Endometrial cancer recurrent Arginase deficiency Glomerulonephritis Cardiac amyloidosis Corneal neovascularisation Cutaneous T-cell lymphoma stage I Still's disease Primary adrenal insufficiency Juvenile idiopathic arthritis More trials…

    Learn about Rare Diseases

    Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Prolymphocytic leukaemia Ocular melanoma Congenital nephrogenic diabetes insipidus – Trials in Disease Usher’s syndrome – Treatment Malignant fibrous histiocytoma – Treatment Primary hyperoxaluria Rhabdomyosarcoma Arterial tortuosity syndrome – Treatment Mast cell activation syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Magnesium Oxide, Light Dopamine Hydrochloride Calcium Levofolinate Favezelimab Ttf-Ngr RPTR-1-201 Deupirfenidone Fludarabine Phosphate Ph. Eur. Opevesostat Df1001 Nms-03305293 Zalunfiban Argon Dalbavancin Cisplatin Lonapegsomatropin Apremilast Canakinumab Ixekizumab METAMIZOLE SODIUM More therapies…

    Learn about Your Condition

    Iron overload Binge eating Pyelonephritis Plasma cell myeloma refractory Viral infection Ovarian cancer recurrent Infantile apnoea Colon cancer metastatic Desmoid tumour Coronary artery dissection Hidradenitis Oesophagogastroscopy Spondylolisthesis Endocarditis enterococcal Premature rupture of membranes More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on the Effectiveness of Lenzumestrocel for Treating Knee Cartilage Defects in Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cartilage injury
    • Chondropathy
    • Chondroplasty
    Investigated Drugs:
    • Lenzumestrocel
    Czechia

  • Study on Adding Diclofenac to PD-1 Inhibitor Therapy for Patients with Metastatic Melanoma

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Metastatic malignant melanoma
    Investigated Drugs:
    • Pantoprazole
    • Diclofenac Sodium
    • Nivolumab
    Germany

  • Study on the Effects of Injectable Gentamicin for Patients with Moderate to Severe Congenital Ichthyosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ichthyosis
    Investigated Drugs:
    • Gentamicin Sulfate
    France

  • Study of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis Who Have Not Responded Well to Previous Biologic Treatments

    Recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Risankizumab
    Belgium Denmark Estonia Germany Greece Hungary +4

  • Study on the Effects of Belimumab in Adults with Systemic Sclerosis-Associated Interstitial Lung Disease

    Recruiting

    4 1 1
    Investigated Diseases:
    • Interstitial lung disease
    • Systemic scleroderma
    Investigated Drugs:
    • Belimumab
    Belgium Denmark Finland France Germany Greece +2

  • Study Comparing Isotretinoin with Doxycycline, Tretinoin, and Adapalene for Moderate Acne in Patients with Skin of Color

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acne
    Investigated Drugs:
    • Adapalene
    • Isotretinoin
    • Lymecycline
    France
Previous Page
1 … 13 14 15 16 17 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!